Evidence map›Paper›PMID 29275487›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2018

Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson's disease based on [

Francisco P M Oliveira, Diogo Borges Faria, Durval C Costa, Miguel Castelo-Branco, João Manuel R S Tavares

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Detection of parkinson's disease with neuroimaging modalities using machine learning and artificial intelligence: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Self-normalized Classification of Parkinson's Disease DaTscan Images.Proceedings. IEEE International Conference on Bioinformatics and Biomedicine · 2021
    Article
  19. Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT.European journal of nuclear medicine and molecular imaging · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Francisco P M OliveiraInstitute for Nuclear Sciences Applied to Health (ICNAS), and Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal. francisco.oliveira@fundacaochampalimaud.pt.ORCID 0000-0001-9468-8894
Diogo Borges FariaHPP Medicina Molecular, Grupo Lenitudes Saúde, Porto, Portugal.
Durval C CostaChampalimaud Centre for the Unknown, Champalimaud Foundation, Lisbon, Portugal.
Miguel Castelo-BrancoInstitute for Nuclear Sciences Applied to Health (ICNAS), and Institute for Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
João Manuel R S TavaresInstituto de Ciência e Inovação em Engenharia Mecânica e Engenharia Industrial, Departamento de Engenharia Mecânica, Faculdade de Engenharia, Universidade do Porto, Porto, Portugal.
Champalimaud Foundation · PTUniversidade do Porto · PTUniversity of Aveiro · PTUniversity of Coimbra · PT

Funding

Fundação para a Ciência e a Tecnologia PTDC/BBB-BMD/3088/2012Fundo Europeu de Desenvolvimento Regional (FEDER) CENTRO-07-ST24-FEDER-00205Fundo Europeu de Desenvolvimento Regional (FEDER) NORTE-01-0145-FEDER-000022
6 · The paper itself

Abstract

purposeThis work aimed to assess the potential of a set of features extracted from [

methodsSeven features were computed from each brain hemisphere: five standard features related to uptake ratios on the striatum and two features related to the estimated volume and length of the striatal region with normal uptake. The features were tested on a dataset of 652 [

resultsCross-validation results based on SVM have shown that, individually, the features that generated the highest accuracies were the length of the striatal region (96.5%), the putaminal binding potential (95.4%) and the striatal binding potential (93.9%) with no statistically significant differences among them. The highest classification accuracy was obtained using all features simultaneously (accuracy 97.9%, sensitivity 98% and specificity 97.6%). Generally, slightly better results were obtained using the SVM with no statistically significant difference to the other classifiers for most of the features.

conclusionsThe length of the striatal region uptake is clinically useful and highly valuable to confirm dopaminergic degeneration "in vivo" as an aid to the diagnosis of Parkinson's disease. It compares fairly well to the standard uptake ratio-based features, reaching, at least, similar accuracies and is easier to obtain automatically. Thus, we propose its day to day clinical use, jointly with the uptake ratio-based features, in the computer-aided diagnosis of dopaminergic degeneration in Parkinson's disease.

Indexed as

Image Processing, Computer-AssistedTomography, Emission-Computed, Single-PhotonAgedFemaleHumansMaleMiddle AgedParkinson DiseaseSwedenTropanes2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropaneTropanesClassificationDaTSCAN™Dimensional-based featuresPPMI databaseUptake ratios

Identifiers

PMID29275487
OpenAlexW2778473818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.